Seelos Therapeutics Inc (SEEL)

[growtheport]

Yes it can even with dilution. Before I exited my previous position I posted stocks eventually rise based on fundamentals/projected growth. I also argued APRI needed to demonstrate, via revenues/sales and margin, Vitaros was a viable product.

Any current manipulation of this stock (by traders) has little to do with dilution or the "big boys" "they" are conspiring to keep the price low. The stock has been correctly battered and dumped for all the right reasons. Bad management, production issues, bad distribution agreements, broken promises to shareholders. It has very little credibility with the Street and is hanging on to it's last best hope: Vitaros.

At this point it seems FDA approval is more likely than not which is why I restarted a small position. But if you own any other companies walking the new drug approval road you'll know it can be a difficult journey.

Finally, it's surprising to me if there is a reasonable chance of approval there isn't more insider buying at these depressed prices. My guess is most options are worthless and IF management/BOD was convinced they had a winner here they would buy in. But I don't see the buys.

So, let's keep this real boys. Just as before, when the stock was much higher, there is no attempt to "keep prices low", it's not going anywhere because of dilution, blah, blah, blah. Apricus needs to move product and get US approval. Or this company is toast.